CINJRegulatory
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| High-Dose Aldesleukin and Ipilimumab in Treating Patients With Stage III-IV Melanoma That Cannot Be Removed By Surgery (NCT02203604) | CINJRegulatory | 2014-11-26 |
Track CINJRegulatory automatically
Every clearance here is in the API, with alerts when new ones post.